Pure Bioscience, Inc. (PURE) company profile
Close on Oct 19, 2026Market cap $8.67MP/E –Yield –
About Pure Bioscience
Miscellaneous Chemical Products, SIC 2890
PURE Bioscience, Inc. develops and commercializes antimicrobial products designed to address pathogen and hygienic control challenges across various industries. Its core technology platform utilizes patented silver dihydrogen citrate (SDC), an electrolytically generated stabilized ionic silver molecule. The company's primary products include PURE Hard Surface, an EPA-registered disinfectant and sanitizer for food contact surfaces, and PURE Control, an FDA-approved direct food contact processing aid for poultry and produce. Additionally, it sells multi-purpose cleaners and SILVÉRION, an SDC-based raw material ingredient used in personal care formulations. PURE Bioscience markets its offerings directly and through third-party distributors to food processing plants, food service and restaurant operations, hospitality businesses, healthcare facilities, and commercial buildings.
The company operates within a single reportable segment and conducts its business from principal executive offices in El Cajon, California. Its products are distributed domestically and marketed outside the United States, including registrations in Canada and international sales of its raw material ingredients.
Summary of the business section of Pure Bioscience's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Pure Bioscience, Inc.
- Founded
- 1992
- Headquarters
- El Cajon, CA
- Address
- 771 Jamacha Road #512 92019
- Phone
- (619) 596-8600
- Website
- purebio.com
- Employees
- 11, Jul 31, 2026
- Industry
- Miscellaneous Chemical Products
- Incorporated in
- Delaware
- Fiscal year ends
- July 31
- Auditor
- Weinberg & Company, P.A., Los Angeles, California
Stock & identifiers
- Ticker
- PURE
- Exchange
- OTC
- IPO date
- Aug 8, 1996
- Shares outstanding
- 140M, Oct 29, 2026
- Public float
- $2.98M, Jan 31, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-8 reverse, Aug 15, 2012
- SEC CIK
- 1006028
- FIGI
- BBG000BVNF18
- Share class FIGI
- BBG001S71679
- EIN
- 33-0530289
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Jeffrey Scott Kitchell | President, Corporate Secretary | 12,998 |
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Option awards | Total | vs. prior year |
|---|---|---|---|---|
| Robert Bartlett Chief Executive Officer | $151.90K | $39.40K | $191.30K | -11% |
| Mark Elliott Vice President Finance | $169.20K | $9.40K | $178.60K | -8% |
| Tom Myers Executive Vice President of Technology & Development | $188.00K | $9.40K | $197.40K | -8% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
Employees
Headcount reported in annual reports
“As of October 29, 2026, we have 10 full-time employees and 1 part-time employee. We believe we have successfully attracted skilled and experienced talent; however, the competition for qualified perso”
Corporate history
Events identified from SEC filings
See a number that looks wrong?